BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12851674)

  • 1. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Park IC; Rhee CH; Hong SI; Knox K
    Int J Oncol; 2003 Aug; 23(2):257-68. PubMed ID: 12851674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP.
    An S; Knox KA
    FEBS Lett; 1996 May; 386(2-3):115-22. PubMed ID: 8647264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells.
    Curnock AP; Knox KA
    Cell Immunol; 1998 Aug; 187(2):77-87. PubMed ID: 9732695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procaspase-3 and its active large subunit localized in both cytoplasm and nucleus are activated following application of apoptotic stimulus in Ramos-Burkitt lymphoma B cells.
    An S; Park MJ; Park IC; Hong SI; Knox K
    Int J Mol Med; 2003 Sep; 12(3):311-7. PubMed ID: 12883646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
    Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis.
    Hristov KK; Knox KA; Mitev VI
    Int J Mol Med; 2005 Nov; 16(5):937-41. PubMed ID: 16211267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.
    Schrantz N; Blanchard DA; Mitenne F; Auffredou MT; Vazquez A; Leca G
    Cell Death Differ; 1999 May; 6(5):445-53. PubMed ID: 10381635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
    Kelly K; Knox KA
    Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
    Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
    Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
    Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y
    Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation.
    Sakata N; Kawasome H; Terada N; Johnson GL; Gelfand EW
    J Allergy Clin Immunol; 2000 Mar; 105(3):522-31. PubMed ID: 10719303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos).
    Schrantz N; Auffredou MT; Bourgeade MF; Besnault L; Leca G; Vazquez A
    Cell Death Differ; 2001 Feb; 8(2):152-61. PubMed ID: 11313717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of calpain in caspase activation during B cell clonal deletion.
    Ruiz-Vela A; González de Buitrago G; Martínez-A C
    EMBO J; 1999 Sep; 18(18):4988-98. PubMed ID: 10487751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of JP-8 jet fuel toxicity. I. Induction of apoptosis in rat lung epithelial cells.
    Stoica BA; Boulares AH; Rosenthal DS; Iyer S; Hamilton ID; Smulson ME
    Toxicol Appl Pharmacol; 2001 Mar; 171(2):94-106. PubMed ID: 11222085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM; Huang Y; Fang G; Bhalla K
    Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.
    Alam MK; Davison S; Siddiqui N; Norton JD; Murphy JJ
    Eur J Immunol; 1997 Dec; 27(12):3485-91. PubMed ID: 9464838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.